Medpace (MEDP)
Runs integrated Phase I–IV trials and laboratory services for drug and device developers.
$630.90
After hours+0.11 (+0.02%)
At close$630.79(+1.06%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 89.81% | 25.07M shares | |
|---|---|---|---|
| 712 holders · as of Jun 30, 2026 | |||
| Insiders | 20.41% | 5.70M shares | |
| 10 holders · as of Sep 21, 2026 | |||
| Adds to | 110.22% | ||
27.91M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 110.22%; nothing is left for Other.
13F, as of Jun 30, 2026
712 holders · 25.07M shares · 79 new positions · 289 increased · 307 reduced · 108 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 2.50M | 8.95% | +27.8K | Aug 7, 2026 |
| Price T Rowe Associates Inc /MD/ | 2.07M | 7.42% | +1.78M | Aug 14, 2026 |
| AQR Capital Management LLC | 1.28M | 4.58% | −74.9K | Aug 14, 2026 |
| Vanguard Portfolio Management LLC | 1.13M | 4.06% | +11.7K | Aug 13, 2026 |
| Vanguard Capital Management LLC | 1.03M | 3.68% | +15.7K | Aug 13, 2026 |
| State Street Corp | 710.9K | 2.55% | +28.7K | Aug 7, 2026 |
| Geode Capital Management, LLC | 710.5K | 2.55% | −34.6K | Aug 12, 2026 |
| Wasatch Advisors LP | 636.6K | 2.28% | −137.3K | Jul 10, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| August J. Troendleincl. Medpace Investors, LLC | 20.00% | 5.68M | 13D | Dec 1, 2025 |
| T. Rowe Price Associates, Inc. | 7.20% | 2.07M | 13G | Aug 14, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 17, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 10,880 | $620.40 | 504,273 |
| Sep 16, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 8,770 | $621.29 | 515,153 |
| Sep 15, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 15,971 | $620.84 | 523,923 |
| Aug 27, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 650 | $620.27 | 539,894 |
| Aug 26, 2026 | Robert O. Kraftdirector | Sale | 3,858 | $617.81 | 955 |
| Aug 26, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 4,000 | $620.03 | 540,544 |
| Aug 25, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 673 | $620.38 | 544,544 |
| Aug 24, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 1,983 | $620.23 | 545,217 |
| Aug 21, 2026 | August J. Troendledirector, 10 percent owner, officer: President & CEO | Sale | 13,995 | $624.45 | 547,200 |
| Aug 20, 2026 | Kevin M. Bradyofficer: CFO & Treasurer | Sale | 3,400 | $625.24 | 12,830 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. David Taylor · OH02 | Purchase | $1,001 – $15,000 | May 15, 2026 | May 29, 2026 | |
| Rep. David Taylor · OH02 | Purchase | $1,001 – $15,000 | May 15, 2026 | May 29, 2026 | |
| Rep. David Taylor · OH02 | Purchase | $1,001 – $15,000 | May 15, 2026 | May 29, 2026 |